NeuraccureClinical development
Nearly ten years of design, clinical validation and improvement
About us
About Neuraccure
A technology born from neurological practice, developed to make measurable what clinical examination doesn't always reveal.
Become a userOur mission
An objective measurement in service of clinical practice
The medical literature shows that traditional clinical assessment does not always accurately capture the impact of an injury on brain function. Neurodegenerative disease often begins several years before the first symptoms appear; once diagnosed, clinical course alone does not always allow precise monitoring of its progression. Neuraccure was developed to meet this need for objective assessment.
Neuraccure was entirely designed and developed by a hospital neurologist. Clinical development began nearly 10 years ago, and more than 1,600 subjects have been tested to date.
Trust is built over time
A technology built on clinical experience
Designed by a neurologist
A technology born from medical practice and its real-world needs.
Personnes testées
Un socle clinique et terrain construit auprès de populations diverses.
Founders
Our team
Mikael Cohen
Co-founder, Chief Scientific Officer
Senior hospital neurologist, behind the clinical development of Neuraccure.
David Cohen
Co-founder, CEO
Lawyer, responsible for Neuraccure's business development and structuring.
The origin
A project born from hospital and academic research
Neuraccure is developed by a hospital neurologist practising at Nice University Hospital (CHU de Nice), in collaboration with university research teams.
Supported by MonacoTech
Neuraccure is supported by MonacoTech, a Monaco-based startup incubator that backs high-impact, innovative projects without taking an equity stake.